Home Business Health Surge In Profits For COVID-19 Vaccine Maker BioNTech
Health

Surge In Profits For COVID-19 Vaccine Maker BioNTech

Share
Share

German coronavirus vaccine maker, BioNTech, said on Monday there had been a sharp jump in its sales and profits.

Based in the western German city of Mainz, BioNTech said second-quarter net profit rose more-than-forecast to nearly 2.8 billion euros (3.3 billion dollars), compared with a loss of 88.3 million euros in the same period last year.

Analysts had expected that the company was to report a second-quarter profit of 2.03 billion euros.

Pfizer-BioNTech vaccine, developed in collaboration with the U.S. pharmaceutical group Pfizer, was authorised for use in the United States, European Union and elsewhere starting last year.

Sales in the quarter ended June 30, were estimated at about 5.3 billion euros, compared with 41.7 million euros a year earlier, BioNTech said.

The analysts had expected that the second-quarter sales would come in at 3.4 billion euros.

Net profit topped 3.9 billion euros in the first six months of this year following a loss of almost 142 million euros a year earlier.

Total sales for the first half of the year were just shy of 7.4 billion euros, compared to about 69 million euros in the prior-year period.


Source NAN

Share

Businesstoday Magazine

Businesstoday Conference/Awards

Related Articles

NNPC Ltd Begins Free Cancer Screening Campaign, Targets 3,000 Nigerians

The Nigerian National Petroleum Company Ltd (NNPC Ltd) through NNPC Foundation, its...

World Bank Confirms $500m COVID-19 Grant For Nigeria

The World Bank has announced a 500-million-dollar grant to support Nigeria’s recovery...

18 million Residents To Benefit From Vaccine Preventable Diseases

The Lagos State Government has said that no fewer than 18 million...

Nigeria: FG Unveils Strategic Blueprint To Address Health Sector, Challenges

The Federal Government of Nigeria has announced a strategic plan to overhaul...